2024 annual financial data
Caribou Biosciences 2024 Operating margin
Direct answer
Operating margin was -1,667.16%.
Operating income was -166,616,000 USD and net income was -149,105,000 USD.
Operating cash flow was -138,200,000 USD.
Get free Caribou Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,994,000 USD
- Operating income
- -166,616,000 USD
- Net income
- -149,105,000 USD
- Operating cash flow
- -138,200,000 USD